breast-cancer

Documents about breast-cancer

• The role of m6A modification in R-loop homeostasis in breast cancer cells#325932HAL (France)
• Peripheral Blood T-Cell Receptor Repertoire and Host Immune Background in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy#348402OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA#146479ClinicalTrials.gov
• Racial Disparities and Diagnosis-To-Treatment Time Among Patients Diagnosed with Breast Cancer in South Carolina#228605Scholar Commons
• Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#230469ClinicalTrials.gov
• Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer#332741ClinicalTrials.gov
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer#28305ClinicalTrials.gov
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer#28337ClinicalTrials.gov
• Pharmacology of Adjuvant Hormonotherapy in Breast Cancer#24652Wikidata
• Breast Cancer Knowledge Based System#102085PhilArchive
• Clinical code list - Breast Cancer#206179LSHTM Data Compass
• A Study of Tumor Imaging With Multispectral Optoacoustic Tomography#287525ClinicalTrials.gov
• TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer#373636ClinicalTrials.gov
• Relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis#4568Europe PMC
• Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus#202219Europe PMC
• Basolateral Secretion from Caco-2 Cells Pretreated with Fecal Waters from Breast Cancer Patients Affects MCF7 Cell Viability#238993HAL (France)
• Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.#369847ClinicalTrials.gov
• A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer#256883ClinicalTrials.gov
• Analysis of Circulating Tumor Markers in Blood#127608ClinicalTrials.gov
• Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer#272323ClinicalTrials.gov
• Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer#127593ClinicalTrials.gov
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012#6814OpenAlex
• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA#67893ClinicalTrials.gov
• "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer#174862ClinicalTrials.gov
• LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté#195491ClinicalTrials.gov
• Effects of resistance vs high intensity interval training on myokines and cancer cell suppression in breast cancer survivors: A randomized trial#289406Research Online
• Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study#15438HAL (France)
• What are the benefits of using mammography AI second reads for breast cancer screening in women with dense breasts?#31512DataCite
• What are the benefits of using mammography AI second reads for breast cancer screening in women with dense breasts?#31513DataCite
• Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab‐based breast cancer therapy: Disproportionality analysis using VigiBase#194767OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Artificial intelligence as treatment support in breast cancer: current perspectives#215458IRIS
• QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy#300263ClinicalTrials.gov
• Percentage Body Fat in Breast Cancer Patients at The University College Hospital, Ibadan: A Case-Control Study#332140University of Ibadan Institutional Repository
• Comparable access, different outcomes: breast cancer survival among syrian refugees and Turkish patients in türkiye#355281Recep Tayyip Erdoğan University Institutional Repository
• Subtype-Divergent Engagement of Aging-Associated Polycomb Programs in Breast Cancer TWAS Identifies Transcriptional and Lysosomal Vulnerabilities#344078Figshare
• Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC#230401ClinicalTrials.gov
• Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors#154646ClinicalTrials.gov
• Prognostic disclosure in metastatic breast cancer: a scoping review.#9559PubMed
• Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer#272342ClinicalTrials.gov
• Interim Breast MRI for Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer.#297202NCBI PubMed Central
• Human brain pericytes protect the blood–brain barrier from triple‐negative breast cancer cells while promoting tumor aggressiveness#156244HAL (France)
• Plasma metabolites, dietary intakes, and breast cancer incidence: a prospective case-cohort study in NutriNet-Santé#218188HAL (France)
• A risk assessment of bisphenol A in luminal A breast cancer via fault tree analysis#224577IDEALS @ University of Illinois Urbana-Champaign
• Vaccine-Related Lymph Nodes#301208HAL (France)
• Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32#303696ClinicalTrials.gov
• CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors#148767ClinicalTrials.gov
• Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)#254361IRIS
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries#6802OpenAlex
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries#6803OpenAlex
• Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.#329526ClinicalTrials.gov